

A thymoma forms in the epithelial cells of the thymus gland, sitting behind the breastbone in the anterior mediastinum. It’s the most common tumour found in that part of the chest, roughly one in four mediastinal masses. Growth is usually slow. Patients hear that and assume it can wait. It can’t, not indefinitely. Given enough time a thymoma pushes into the lung, the pericardium, the vessels running past it, and in a small number of cases it turns into thymic carcinoma, which is a much harder tumour to operate on.
According to Dr. George Karimundackal, a leading Thoracic Surgeon in Mumbai, “People think slow growing means there’s no urgency. Sometimes that’s fine. But a thymoma caught early is a clean operation with good long term survival. Catch the same tumour a year later, once it’s grown around a vessel, and you’re looking at a completely different surgery. Timing matters more than most patients realise.”
Many thymomas cause no symptoms at all and turn up by accident on a scan done for something else.
CT chest with contrast maps the tumour, and once a mediastinal mass is flagged, a proper surgical evaluation should begin with a consultation for mediastinal surgery.
Surgery is the standard treatment for resectable thymoma at every stage, with complete resection driving long term outcome.
Every decision here needs a proper multidisciplinary review, and understanding how thymoma differs from thymic carcinoma is covered in thymoma vs thymic carcinoma.
Dr. George Karimundackal, MBBS, MS (General Surgery), MCh (Surgical Oncology), MRCS Edinburgh, is Director of Thoracic Surgery at Nanavati Max Super Speciality Hospital, Mumbai. Fifteen years working exclusively in thoracic surgery, over a thousand minimally invasive procedures, and published research specifically on thymic tumour behaviour and thymoma linked myasthenia gravis. That kind of mediastinal experience is uncommon outside dedicated thoracic oncology centres. Every thymoma case here goes through a full tumour board review before any surgical plan is finalised.
Yes. Thymoma is classified as a malignant tumour, though a low-grade one. It rarely spreads to distant organs, but it can invade nearby structures if left untreated, which is why it always requires proper evaluation and treatment.
Surgery is standard when the tumour is resectable. Chemotherapy or radiation come in only when surgery isn’t possible, or alongside it in advanced cases.
For Stage I and II thymoma with complete resection, five-year survival is around 91 percent and ten-year survival around 74 percent. Survival is lower at Stage III and IV, where treatment is more complex.
In about 30 to 50 percent of cases, yes. Removing the thymus often resolves or significantly improves these symptoms.
WhatsApp us